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Objectives 
• Define the role of the Mass Health (MH) Special 
Populations pharmacist within Community Case 
Management (CCM) 
 
• Demonstrate value added component of the MH 
Special Populations program utilizing case 
studies 
 
• Provide program related cost savings and cost 
avoidance data 
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Impact of Poor Medication 
Adherence 
• Additional medical costs related to physician, 
hospital, and emergency room visits 
 
• 33% to 69% of medication-related hospital 
admissions 
 
• 89,000 deaths annually 
 
• $100 billion per year in hospitalization costs 
alone 
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From: Osterberg L, Blaschke T. Adherence to medication.  N Engl J Med 2005; 353:487-497. 
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UMass Medical School  
and Commonwealth Medicine 
• UMass is the only state-operated, non-profit academic  
medical school in Massachusetts 
• A multi-faceted organization with deep clinical, health care 
finance, health policy, research and health care operations 
expertise 
• In 1999, UMass founded Commonwealth Medicine (CWM) 
to share UMass Medical School expertise with public 
agencies 
• CWM designs, implements, operates and evaluates a wide 
range of health care programs nationwide – leveraging 
resources across the UMass system 
• CWM currently includes 1,600 FTEs 
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• Correctional Health 
• Disability Evaluation Services 
• Clinical Pharmacy Services 
• Care Management 
• Clinical and Administrative 
Call Centers 
• Newborn Screening 
• Prior Authorization and 
Utilization Management 
• Health Care Reform 
• Health Policy Analysis 
• Health Economics 
• Health Law Advice and 
Analysis 
• Health Law Compliance 
• Data Analysis and Decision 
Support 
• Policy Development 
• Outcomes and Evaluation 
Research 
• Medical Leadership 
• Workforce Development, 
Education and Training 
• Cost Avoidance 
• Third Party Identification 
• Program Integrity 
• Federal Claiming 
• Estate / Accident Recovery 
• Medicare Appeals 
• Coordination of Benefits 
Health Care Operations 
and Administration 
Health Law 
and Economics 
Research, Evaluation 
and Training 
Health Care Financing 
Central Office 
Project Management / Program Development • Communication and Client Relations 
Custom Consulting • Human Resources • Marketing Analytics • Information Technology 
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CCM Overview 
• Developed in 2003 
• UMASS Medical School functions as an agent 
of MA Medicaid (MassHealth):  
Perform coordination and authorization of 
MassHealth Community Long Term Care (CLTC) 
Services  
To a defined MassHealth population of medically 
complex individuals   
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CCM Eligibility Criteria 
• Under the age of 22, upon referral 
Referrals sources can be Members, Families, 
Hospitals, Physicians, Clinicians, etc. 
• CCM RN conducts an in-person assessment 
to determine if the Member qualifies for 
MassHealth coverage of Continuous Skilled 
Nursing (CSN) services 
Greater than 2 continuous hours in duration 
Medically Necessary per MassHealth Regulations 
• Reassessments completed on an annual 
basis 
CLINICAL PHARMACY SERVICES 
CCM as Single Point of Entry 
• CCM RNs serve as single point of entry for 
MassHealth CLTC Services 
• Facilitate access to services within MassHealth, 
other state agencies, third party insurers 
• Multidisciplinary Team of professionals coordinate 
and authorize: 
 CSN Services, Skilled Nursing Visits, Home Health Aides 
 Personal Care Attendant (PCA) Services 
 Durable Medical Equipment & Supplies 
 Oxygen & Respiratory Equipment & Supplies 
 Therapy Services (Physical, Occupational, Speech) 
 Enteral and Absorbent Products 
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The  Relationship 
  
 
 
 
University of             
Massachusetts Medical School 
Commonwealth Medicine 
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1998 - MassHealth (MH) DUR Program 
Massachusetts Division of Medical Assistance 
• Comprehensive program ensuring appropriate 
drug therapy for 1.1 million MA Medicaid lives  
 
• Provides prospective and retrospective DUR 
 
• CPS advises and presents at monthly DUR 
Board meetings comprised of 12 selected 
health care professionals within MA  
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DUR 
CPS 
CWM 
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The Relationship 
 
DCS 
CCM 
CLINICAL PHARMACY SERVICES 
Integration of Pharmacy Services into 
Community Case Management 
1998 
• MH DUR 
Established 
2003 
• CCM 
Established 
2006 
• Integration of 
Pharmacist 
into CCM 
Program 
13 
CLINICAL PHARMACY SERVICES 
Pharmacy Assistance with 
Medication Procurement for CCM  
 
• Pharmacy billing 
 
• Prior authorization 
 
• Dual eligible billing 
 
• Discharge planning 
 
• Disaster planning 
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Integration of a Pharmacist into 
CCM Program Activities 
• Provide medication management services 
• Antiepileptic therapy 
• Pain management 
• Mitochondrial disease 
• Ketogenic diet 
• Attend multidisciplinary team meetings 
• Accompany clinical manager on home 
visits 
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Case Study 
 
• 22 year old member 
• Rare neurodegenerative disease 
• Diagnosis at age 17 
• Medications 
• Six anticonvulsants 
• Four supplements 
• Three pulmonary medications 
• Multiple ‘over the counter’ medications 
• Medications administered nine times daily 
16 
CLINICAL PHARMACY SERVICES 
Case Study 
Pharmacist Interventions 
• Assistance with: 
• Acquisition of syringes to administer 
medications 
• Prior authorization assistance 
• Procurement of supplement (coenzyme 
Q10) 
• Dual eligible issue 
(Medicare/Medicaid/Private Insurance) 
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Case Study 
Pharmacist Interventions 
• Discharge planning 
 
 
• Pain management consult 
 
 
• Protocol for seizure management 
 
 
• Consultation with multiple prescribers 
 
 
• Communication with pharmacies 
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Outcomes of Pharmacy Service on 
a Drug Utilization Review Program 
• Identification of members potentially 
impacted by changes 
• Increased awareness on part of prior 
authorization reviewers 
• Population specific guideline 
development and modifications 
• Outreach to ensure continuity of care 
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Impact of Pharmacist Services: 
Return on Investment of 4:1 
• Cost savings 
• Less costly alternatives 
• Third party liability 
• Hospital/emergency room/MD visit avoidance 
• Unnecessary medication 
•  Cost avoidance 
• Prevention of adverse drug reaction 
• Improved adherence 
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Conclusions 
• This collaborative effort between MH and 
Commonwealth Medicine represents an effective 
strategy to enhance the quality of care for medically 
complex members 
• The MH Special Populations pharmacy program 
continues to expand  
• Cost avoidance/cost saving data supports the value 
added component of this program 
• Pharmacy services can contribute to improved 
patient outcomes and the success of case 
management programs 
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